Cognitive side effects of cancer therapy demonstrate a functional role for adult neurogenesis

Behav Brain Res. 2012 Feb 14;227(2):376-9. doi: 10.1016/j.bbr.2011.05.012. Epub 2011 May 23.

Abstract

Cancer therapies frequently result in a spectrum of neurocognitive deficits that include impaired learning, memory, attention and speed of information processing. Damage to dynamic neural progenitor cell populations in the brain are emerging as important etiologic factors. Radiation and chemotherapy-induced damage to neural progenitor populations responsible for adult hippocampal neurogenesis and for maintenance of subcortical white matter integrity are now believed to play major roles in the neurocognitive impairment many cancer survivors experience.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antineoplastic Agents / adverse effects*
  • Cognition / drug effects*
  • Cognition Disorders / chemically induced*
  • Hippocampus / drug effects*
  • Humans
  • Neoplasms / drug therapy*
  • Neural Stem Cells / drug effects
  • Neurogenesis / drug effects*
  • Neurons / drug effects*

Substances

  • Antineoplastic Agents